PeptideScanner

Source coverage

What we cover—
and what we don't.

Every factual profile and update claim is mapped to a cited record below. This beta is a selective index of official U.S. sources—not a complete literature review or a continuous monitor of peptide news.

Currently covered

Selected ClinicalTrials.gov studies, specific DailyMed U.S. label versions, and selected FDA and Justice Department records, including FDA GSRS identifiers.

How records appear

A human reviewer chooses the source, checks the wording against it, and publishes the record. AI assistance cannot publish on its own.

Known gaps

Coverage is not exhaustive—even within a listed peptide. It does not yet systematically cover PubMed, non-U.S. regulators, company announcements, or secondary reporting.

Public citations

54 cited records

ClinicalTrials.gov

Official source · 10 cited records

DailyMed · U.S. National Library of Medicine

Official source · 22 cited records

U.S. Food and Drug Administration

Official source · 16 cited records

U.S. Department of Justice

Official source · 1 cited record

FDA Global Substance Registration System

Official source · 5 cited records

How we use sources

Official and primary records

Regulators, trial registries, government notices, and official label repositories. These sources support only what that body recorded or did.

Company or institutional statements

Claims remain explicitly attributed and are never presented as independent conclusions.

Secondary reporting

Useful for discovery and context. PeptideScanner prefers an underlying primary record whenever one is available.

Public beta · Selective source coverageNot medical advice · No dosing or purchasing guidance